chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 9/11/2023 Discharge Date: 9/14/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypokalemia [E87.6] Generalized weakness [R53.1] COVID-19 [U07.1]   Admission H&P: Patient is a 94 y.o. female with prior medical history of AFib, CHF, GERD, hyperlipidemia, hypothyroidism and who presents today with weakness, fatigue and cough.  The patient reports falling at home on Friday when she was getting up to take her morning dose of Synthroid she suddenly fell to the ground.  She does not recall hitting her head or losing consciousness.  She reports possible lightheadedness prior to falling and notes that she has been feeling unsteady since the fall.  Denies any headache prior to fall.  She does have a remote history of seizures but denies any recent seizure activity.  Denies chest pain, or shortness a breath.  She does have a nonproductive cough which started around Friday as well.  She reports significant fatigue and weakness.  She lives at home alone and typically independent with ADLs.  She reports minimal orally intake over the past 3 days.  Denies any fevers but does endorse chills.  Has mild discomfort in her back and left side of the chest but has not required anything for pain .   In the emergency department several scans were completed including CT cervical and thoracic spine which were both negative for acute process.  CT thorax no evidence of trauma and unchanged small pericardial effusion.  CT of the head was negative for acute process.  Labs revealed a mild worsening of creatinine of 1.51 and potassium of 3.0.  Potassium was replaced in the emergency department she was also found to be COVID-19 positive.  An order for orthostatic vital signs and ambulatory pulse ox was placed however the patient was too weak to ambulate.  Admit to hospitalist service for physical therapy occupational therapy and IV fluid resuscitation.   HOSPITAL COURSE:  94 years old woman presented after a fall due to generalized muscle weakness. She was found to have COVID positive and acute kidney injury. AKI resolved with IV fluids and HCTZ 12.5 mg was discontinued on discharge since it worsened her kidney function. Her BP remained controlled on amlodipine 2.5 mg BID, so BP needs to be managed outpatient per PCP. PT and OT recommended discharge to home with home health care services. For COVID 19, no remdesivir was given was because of her AKI and reduced creatinine clearance. No paxlovid was given on discharge either due to low creatinine clearance per pharmacy. Patient was not requiring oxygen inpatient. Patient was discharged in hemodynamically and clinically stable state. For GERD, pantoprazole 20 mg daily was continued but famotidine dosing was adjusted to 20 mg every other day due to renal adjustment per pharmacy.
Onset 10/29/05: Extreme deep body chills, body aches, joint pain, general lethargy, loss of appetite, fever to 104F, headache, chest congestion, cough, stuffy head, runny nose. Total loss of energy  and motivation continues at day 10 of onset. 5 days work lost 11/7/05. Script: cough syrup w/codeine, Eval.  for chest x-ray.
Information has been received from a certified medical assistant (CMA) concerning a 9-year-old male with a concurrent condition of asthma, who was vaccinated at the pediatricians office with a dose of varicella virus vaccine live (Oka/Merck) on 13-SEP-1999. There was no illness at the time of vaccination. Concomitant therapy included albuterol. On 28-MAY-2007 (also reported as 29-May-2007), the patient presented with chickenpox. The symptoms included, headache, fever, sneezing and vesicles on his right lower chest, left upper quadrant of abdomen, sternal area, right lower quadrant of abdomen, anterior aspect of right distal thigh and left and right mid back. Unspecified medical attention was sought. The outcome was reported as recovered. No product quality complaint was involved. Additional information is expected.
Headache, Myalgia & NauseaVomiting  Other Relevant History:
Tachycardia from 100 bpm to 120 bpm for an approximately 5 hour period (2:00 pm to 7:00 pm)
Body aches, chills, loss of appetite, fever, night sweats, headache. Symptoms started 2/19/2020 in the evening and lasted through Sunday, 2/21/2020.
Fever 102.2 orally , chills, shaking, headache, fatigue, sweating, thirst lasting approximately 12 hrs. Tx; 2 EX strength Tylenol, bed rest, sleep.
Sever Symptoms of Sinus infection, resulting in sore throat, sinus drainage, dizziness, loss of apatite. symptoms are preistent and ongoing.
Patient began vomiting, c/o dizziness & H/A, blurred vision, photophobia after flu vaccine. Sent to ER for eval. Final ER diag: viral illness. Rx's ZOFRAN PRN, ANTIVERT TID x3 days.
Patient came in for very first dose of covid vaccine, accidently was given Pfizer bivalent booster instead of monovalent. Patient made aware that she received bivalent instead of monovalent dose. Patient did not report any adverse reaction.
Information has been received from a pharmacist referring to 4 newborns. Background: Since June 2015, there had been 1645 times (30 minutes each time= 822.5 hours) that the temperature dropped below 36F. Of course, there was 144 times (30 minutes each time=72 hours) that temperature was below 32F, the lowest being 29.7F. On 04-JUL-2015, there was a low temperature of 30.2F. On 08-JUL-2015 the patients were vaccinated with the improperly stored RECOMBIVAX HB strength 2.5/0.5 (units not provided) (lot number K020216 and expiration date of 17-SEP-2016) (dose and route of administration were not reported). There was no product quality complaint (PQC). This is one of several reports received from the same reporter. Additional information has been requested.
tired later in the day; Sinus Headache; Bumps on the back of my throat; This spontaneous case was reported by a consumer and describes the occurrence of SINUS HEADACHE (Sinus Headache), THROAT IRRITATION (Bumps on the back of my throat) and FATIGUE (tired later in the day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Sinus headache.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced SINUS HEADACHE (Sinus Headache) and THROAT IRRITATION (Bumps on the back of my throat). On an unknown date, the patient experienced FATIGUE (tired later in the day). The patient was treated with CETIRIZINE HYDROCHLORIDE (ALLERGY & HAYFEVER RELIEF) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, SINUS HEADACHE (Sinus Headache), THROAT IRRITATION (Bumps on the back of my throat) and FATIGUE (tired later in the day) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       concomitant medications were not provided by reporter. Upon internal review on 21May2021, the age was corrected to unknown age.       Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Dosage information was updated, AE contact information update, event was updated. patient reported she believes she had more of an anxiety related experience then an reaction to the Moderna covid vaccine. causality updated.
Moderna killed my mother 4 September 2021; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DEATH (Moderna killed my mother 4 September 2021) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on 04-Sep-2021 The patient died on 04-Sep-2021. The cause of death was not reported. It is unknown if an autopsy was performed.            Concomitant and treatment medications were not reported.  Company comment: This is a spontaneous case female patient of unknown gender, with no medical history, who experienced unexpected fatal serious (medically significant) event of death (reported as Moderna killed my mother 4 September 2021), which occurred unspecified days after a dose of mRNA-1273 vaccine. Death occurred on 04-Sep-2021. The cause of death was not reported. It is unknown if an autopsy was performed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-695779.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-695779:Father in law's case; Reported Cause(s) of Death: unknown cause of death
received the second dose 3 months after the first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose 3 months after the first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose 3 months after the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose 3 months after the first dose) outcome was unknown. Not Provided          Treatment reported as none. No concomitant medications reported.
Pt received PREVNAR 13 on 5-5-15 approx. 8:30 am. She later reported an episode of syncope which resulted in an MVA around 3PM. She was transported by ambulance to the ER.
Pt called in,  reported he was having a reaction to a vaccine he received on 12/4/01 in L arm. Review of record determined it was the pneumonia vaccine. Pt c/o redness, soreness, swelling and streaking. Advised to f/u  w/MD. Saw MD - no recommendation or f/u necessary, Adverse reaction.
Stable lupus with normal cell counts for years, received second dose Moderna vaccine 4/3/2021 and had 2 days of malaise however then developed increasing fatigue and weakness. Presented to outside hospital on 4/10/2021 and found to have profound thrombocytopenia, mild lymphopenia and anemia.
Rt arm swelling, red streaks, unable to lift arm, pain. Tx: antibiotic and rest.
vaccine given after 24 hrs of opening of the vial; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Apr-2021 and was forwarded to Moderna on 15-Apr-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION ERROR (vaccine given after 24 hrs of opening of the vial) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION ERROR (vaccine given after 24 hrs of opening of the vial). At the time of the report, PRODUCT ADMINISTRATION ERROR (vaccine given after 24 hrs of opening of the vial) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: TCR doc attached and contains No new information. Reporter confirmed he'd like to close the case
This is a spontaneous report received from a contactable consumer (patient) via a Pfizer-sponsored program Support.  A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Lot number: Unknown) via an unspecified route of administration on 04Feb2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history included cancer. The patient concomitant medication was PEMBROLIZUMAB for cancer and last dose was on 09Feb2021. On an unspecified date in Feb2021, the patient experienced arm pain and not feeling well after the administration of first dose. It was reported that the patient received first dose on 04Feb2021 and was scheduled for second 18Feb2021. She missed the second dose due to weather and not feeling well. Potentially scheduled for this Thursday. The clinical outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Shingles - Symptoms: rash on torso, vibration on ribcage - Treatment: Valacyclovir
I had a headache most of the day and then woke up at 1AM with a  fever of 102.5 and no other symptoms.
Fever, chills,  nausea, vomiting, body aches, fatigue, headache, sore left arm, can?t lift left arm for 48 hrs due to pain, sweating and clammy on head, neck, inner elbows and behind knees.  Barely No appetite for 24 hrs.   Day 3 still got chills and fever and clammy body with sweating and fatigue.
This spontaneous report as received from a physician via a field representative refers to a female patient of unknown age. No demographics were provided for the patients, other than the gender. The pertinent medical history and drug reactions/allergies were unspecified by the reporter. On an unknown date, patient was vaccinated with PNEUMOVAX23 (dose, route and lot number not reported). Concomitant medication at the time of event was unspecified by reporter. On an unknown date, patient experienced cellulitis at the injection site, after receiving PNEUMOVAX23. The patient was treated with antibiotics (unspecified name, dose/frequency and manufacturer). The event cellulitis was recovered on an unspecified date. The patient sought medical attention, and made an office visit on an unspecified date. No product quality complaint  (PQC) was reported. The causality was not reported.  This is one of the two cases reported by the same reporter. Additional information has been requested.
This spontaneous report was received from a healthcare professional and refers to a currently 12 months old, female patient. The patient's medical history and concurrent conditions were not reported. On 26-OCT-2015, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX lot # L008270 with expiration date 11-MAR-2017 (dose, and route of administration were not provided). No concomitant medications were reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected as all scheduled follow up information was received.
Patient mistakenly received 2 doses of Arexvy vaccine approx. 1 week apart (1st dose 9/11/23 at another pharmacy). This patient scheduled an appointment with us to get his dose of Arexvy and was given it by staff who believed it was his 1st and only dose. It was discovered later that he had received it previously from another one of our pharmacies where he had scheduled an appontment with them for this vaccine as well.  No actual adverse reactions as of yet as a result of these vaccinations.
I started having symptoms of COVID-19. I had chest congestion, body aches, sore throat, no fever, cough. I tested with a home COVID-19 test that show negative for three days. On day four after the test show positive for COVID-19 I called my doctor to let her know I had tested positive for COVID-19. I alternated between taking ibuprofen and TYLENOL as I was breastfeeding. My pregnancy due date 12/23/2021, delivered shortly after that, birth weight 7lbs 3oz, pregnancy was a good one nothing out of normal.
Monday night after I received the shot and my arm was in severe pain. The next night I was asleep and a woke with chills, cough, and nausea. I vomited twice. and fever and arm pain. 10-5am
States experienced a few minutes of vertigo while hiking a day after taking the first dose, then again a few hours after taking the second dose and a few more times over the next couple of days. Pt states she is still experiencing periodic vertigo and has left a message for her doctor.
Can't move shoulder - extreme pain  17 days of not moving arm and pain.  Injection was too high, vaccine in rotator cuff tissue. Hasn't dispersed. It's been 17 days.....
Itching, redness, swelling from left deltoid extending to elbow with skin tightness. TO ER seen by MD prescribed Benadryl, cold compresses, return 2 days follow up. Sooner if S/S worsen.
On 6/9/3003 seveal days after recieving a deep cat claw puncture wound on finger, got left deltoid injection of TD. About one month later, noticed a small circular (few mms) inflamed area on left deltoid that was sensitive to touch and itched. Did not associate the irritation with the earlier injection. About a month later it was worse and about the size of a dime. Finally, on October 1, 2003 it was size of a quarter, and quite uncomfortable. Went to dermatologist MD. He did not know what it was. I suggested it might be an insect bite reaction. He removed it and sent some material in to be biopsied. I then went home and for the first time, remembered the tetnus injection. Checked my medical records and decided I had probably had a reaction to the vaccine. I called Dr. back and discussed the issue with him. The biopsy report was consistet with a reaction to the tetnus injection. diagonsed a "Persistent Hypersensitiviy Reaction" The biopsy report revealed: "Dense demal lymphoid infiltrate with atypia", and "Cutaneous lymphoid hyperplasia." The surgery has healed. I have no symptoms in that area outher than a quarter sized red area.   where surgical would was. I am following up becuase neither physician is sure whether it would be safe for me to ever again recieve a tetnus booster shot. It seemed appropriate to file this report prior to making more formal inquires. Dr. stated his recommendation would be to not have further tetnus shot injections. But, he stated he was not certain.
Pain in left arm at bed time day of flu shot. In AM could not move arm w/o pain. Pain subsided somewhat but now, 2 weeks after injection can not raise arm more than 45 degrees without pain and can not put pressure on arm.
Starting in early 07/2022, I developed a very bad head cold. I took a COVID-19 test at home which came back negative. It ended up being a sinus infection with bad sinus drainage. I went to see the Nurse Practitioner at my Drs office on 07/12/2022 and she prescribed me Amoxicillin and Clavulanate Potassium, which made me sick for 4-5 days. I stopped it due to making me sick and I hadn't taken it for 4 days and went to the ER on 07/24/2022. They diagnosed me with a UTI (marginal) and they did a scan to make sure I didn't have kidney stones. They prescribed me cefdinir and my UTI went away in 2 days. My head was still congested at the time I went to the ER but it no longer is now and I still have a few days of the medicine to take. I am feeling better now.
fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided. No treatment medications was provided.   This case was linked to MOD-2021-255983, MOD-2021-023260 (Patient Link).; Sender's Comments: Based on the current available information, a causal relationship cannot be excluded. Further information has been requested regarding vaccination and event dates.
This spontaneous report as received from a pharmacist refers to a 61 years old female patient with no pertinent medical history. The patient was vaccinated with ZOSTAVAX (lot number 0564AE, expiration date 21-MAR-2013) on 22-AUG-2012. There were no concomitant medications. The patient developed an injection site reaction about 3 days after vaccination approximately on 25-AUG-2012. The patient developed an injection site reaction described as a red (erythematous), swollen, itchy, painful and warm to touch area at the injection site that was about 3 inches in diameter and raised about a half inch. No treatment or laboratory diagnostics studies were performed. The injection site reaction resolved without treatment (unspecified time frame). The patient had sought unspecified medical attention on 07-SEP-2012. Additional information is not expected.
This case was reported by a lawyer and described the occurrence of mercury poisoning in a male subject aged between 0 and 9 years old who was vaccinated with Engerix B. A physician or other health care professional has not verified this report. The subject was also vaccinated with Hib vaccine, Dtap, OPV, Tetramune, and MMR vaccine. The subject was vaccinated with Engerix B vaccine on 09 April 1993, 13 May 1993 and 19 November 1993. At an unspecified time after vaccination, the subject experienced mercury poisoning. According to the legal complaint, the subject suffered and in the future will continue to suffer from the toxic neurological effects of mercury poisoning. This case was assessed as medically serious by manufacturer (OMIC). At the time of reporting the events were unresolved.
ADMINISTRATION ISSUES: The vial was previously punctured on 11/30/2021.  The patient didn't have any side effects or adverse reactions.  The patient will be re-vaccinated ASAP.
Fever, meningismus, seizure activity. He prescribed to ED on 7/18 w/ meningismus and fever. Treated w/ Ceftriaxone, Vancomycin, and Acyclovir. Developed seizure on 7/20, transferred to ICU from ID, treated w/ Dilantin and completed 7 day course Ceftriaxone, Acyclovir and Vancomycin discontinued.  7/31/07 Received vax records from pcp which confirm RO lot & dose #as reported.  9/14/07 Reviewed hospital medical records which reveal patient experienced irritability, decreased oral intake, fever.  Seen in ER on 7/17, labs done, given IM antibiotic & D/C to home.  Seen by PCP again on 7/18 w/o improvement & sent back to ER.  Found to have bulging anterior fontanelle.  LP done & 2nd dose of IM antibiotics given.   Admitted 7/18-7/26/06 to peds ID.  Neurology consult done.  Developed status epilepticus on 7/20 & had to be emergently intubated.  Extubated next day.  LP repeated on 7/25.  D/C to home on antiseizure med. FINAL DX: Aseptic  meningitis; convulsions.